Asymmetry Capital Management

Asymmetry Capital Management as of March 31, 2021

Portfolio Holdings for Asymmetry Capital Management

Asymmetry Capital Management holds 29 positions in its portfolio as reported in the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Jazz Pharmaceuticals (JAZZ) 6.3 $12M 74k 164.37
Sotera Health (SHC) 6.0 $12M 467k 24.96
Adaptive Biotechnologies Cor (ADPT) 6.0 $12M 288k 40.26
Vertex Pharmaceuticals Incorporated (VRTX) 6.0 $12M 54k 214.89
Arena Pharmaceuticals 5.9 $11M 163k 69.39
Insulet Corporation (PODD) 5.8 $11M 43k 260.91
UnitedHealth (UNH) 5.7 $11M 29k 372.07
Astrazeneca Plc-spons Adr (AZN) 5.6 $11M 219k 49.72
Guardant Health (GH) 4.9 $9.5M 62k 152.64
Nanostring Technologies (NSTGQ) 4.8 $9.4M 143k 65.71
Biodesix (BDSX) 4.7 $9.0M 444k 20.31
Essa Pharma (EPIX) 4.3 $8.3M 285k 29.05
Kura Oncology (KURA) 4.1 $7.8M 278k 28.27
Arcus Biosciences Incorporated (RCUS) 3.4 $6.6M 237k 28.08
Avadel Pharmaceuticals Adr (AVDL) 3.3 $6.4M 712k 9.04
Sage Therapeutics (SAGE) 3.1 $6.0M 80k 74.85
Jounce Therapeutics 2.8 $5.3M 521k 10.27
Aslan Pharmaceuticals Lt- Adr 2.3 $4.5M 1.4M 3.35
Mirati Therapeutics 2.1 $4.2M 24k 171.29
Renalytix Ai Plc- Adr (RNLX) 2.1 $4.1M 161k 25.66
Pmv Pharmaceuticals (PMVP) 2.0 $3.9M 118k 32.89
Mereo Biopharma Group Plc ads (MREO) 1.9 $3.6M 1.1M 3.37
Iteos Therapeutics (ITOS) 1.8 $3.5M 102k 34.18
Regulus Therapeutics 1.6 $3.1M 2.0M 1.56
Apricus Biosciences 1.1 $2.2M 441k 4.99
Forte Biosciences (FBRX) 0.9 $1.8M 53k 34.27
Turning Point Therapeutics I 0.6 $1.1M 12k 94.58
Bcls Acquisition Corp 0.5 $871k 82k 10.57
Galecto (GLTO) 0.4 $690k 114k 6.08